We encourage you to utilize these resources. If you have any further questions or require any additional information about Prolia, please contact Amgen Medical Information at 1-866-502-6436, or visit Amgen Medical Information.
2010 Clinical Practice Guidelines
For the diagnosis and management of osteoporosis in Canada
ProVital® Enrolment Form
Download the ProVital® Patient Support Program enrolment form
FREEDOM Trial
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Prolia® Product Monograph
Access a downloadable version of the Prolia® Product Monograph
Frequently Asked Questions
Answers to questions your patients may have about Prolia
References
1. | Prolia (denosumab injection) Product Monograph. Amgen Canada Inc., November 24, 2023.. | 2. | Cummings SR, et al. N Engl J Med 2009;361(8):756-65. |